Incruse Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) for long-term, once-daily maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD). Incruse Ellipta is also known by its drug name, Umeclidinium bromide.

Incruse Ellipta is an anticholinergic drug and a long-acting bronchodilator, or drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Incruse Ellipta is believed to work by relaxing smooth muscles in the airways.

How do I take it?
Incruse Ellipta is taken once daily.

Incruse Ellipta comes in the form of powder packaged in a foil bli... read more

Incruse Ellipta (Umeclidinium bromide) Questions

MyCOPDTeam is a free social network that makes it easy to find others like you and gain insights from others living with COPD.
Sign up Log in